NCT05245500 2025-12-05Phase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionBristol-Myers SquibbPhase 1 Recruiting336 enrolled
NCT01169584 2016-01-21Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsSillaJen, Inc.Phase 1 Completed6 enrolled